179 related articles for article (PubMed ID: 9809903)
1. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.
Reimold SC; Maisel WH; Antman EM
Am J Cardiol; 1998 Oct; 82(8A):66N-71N. PubMed ID: 9809903
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
Rae AP
Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
[TBL] [Abstract][Full Text] [Related]
4. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Magnani B
Ann Intern Med; 1997 Apr; 126(8):621-5. PubMed ID: 9103129
[TBL] [Abstract][Full Text] [Related]
5. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
Stroobandt R; Stiels B; Hoebrechts R
Am J Cardiol; 1997 Feb; 79(4):418-23. PubMed ID: 9052343
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
Kishore AG; Camm AJ
Drugs; 1995 Aug; 50(2):250-62. PubMed ID: 8521758
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
Mihálcz A; Földesi C; Kardos A; Ladunga K; Szili-Török T
Orv Hetil; 2009 Sep; 150(36):1694-700. PubMed ID: 19709984
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
Podrid PJ; Anderson JL
Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
[TBL] [Abstract][Full Text] [Related]
11. Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation.
Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Branzi A; Magnani B
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2465-9. PubMed ID: 9825368
[TBL] [Abstract][Full Text] [Related]
12. Propafenone: an effective agent for the management of supraventricular arrhythmias.
Grant AO
J Cardiovasc Electrophysiol; 1996 Apr; 7(4):353-64. PubMed ID: 8777484
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation and the pharmacological treatment: the role of propafenone.
Sestito A; Molina E
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):242-53. PubMed ID: 22428477
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
Dogan A; Ergene O; Nazli C; Kinay O; Altinbas A; Ucarci Y; Ergene U; Ozaydin M; Gedikli O
Acta Cardiol; 2004 Jun; 59(3):255-61. PubMed ID: 15255456
[TBL] [Abstract][Full Text] [Related]
15. Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?
Botto GL; Bonini W; Broffoni T; Molteni S; Lombardi R; Alfieri G; Barone P; Bernasconi G; Ferrari G
Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1939-43. PubMed ID: 8945073
[TBL] [Abstract][Full Text] [Related]
16. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
Bellandi F; Dabizzi RP; Cantini F; Natale MD; Niccoli L
Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
[TBL] [Abstract][Full Text] [Related]
17. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
18. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study.
Kochiadakis GE; Igoumenidis NE; Simantirakis EN; Marketou ME; Parthenakis FI; Mezilis NE; Vardas PE
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2475-9. PubMed ID: 9825370
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study].
Gao X; Zhu J; Yang YM; Li JD; Yang ZM; Liu JH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):151-4. PubMed ID: 17445412
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
Kochiadakis GE; Igoumenidis NE; Hamilos ME; Marketou ME; Chlouverakis GI; Vardas PE
Am J Cardiol; 2007 Jun; 99(12):1721-5. PubMed ID: 17560882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
